HR23B, a biomarker for HDAC inhibitors
<p>As our understanding of cancer biology increases and novel therapies are developed, an increasing number of predictive biomarkers are becoming clinically available. Aberrant acetylation has been strongly linked to tumourigenesis and the modulation of acetylation through targeting histone d...
主要作者: | Khan, OA |
---|---|
其他作者: | La Thangue, NB |
格式: | Thesis |
語言: | English |
出版: |
2013
|
主題: |
相似書籍
-
Mitochondrial modulators of hypoxia-related pathways in tumours
由: Snell, CE
出版: (2013) -
Role of HR23B, HDAC6 and Myd88 and their interplay in response to HDAC inhibitor treatment
由: New, M
出版: (2014) -
Angiogenesis in human lung tumours
由: Ferguson, ML
出版: (2008) -
Risk factors for haemorrhage in patients with haematological malignancies
由: Estcourt, LJ
出版: (2014) -
Regulation of stemness and differentiation in colorectal cancer
由: Gandhi, S
出版: (2010)